Biomerica, Inc. BMRA
NASDAQ
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.27M | 875.00K | 987.00K | 1.21M | 1.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.27M | 875.00K | 987.00K | 1.21M | 1.38M |
| Cost of Revenue | 1.16M | 946.00K | 1.03M | 1.16M | 956.00K |
| Gross Profit | 103.00K | -71.00K | -44.00K | 51.00K | 424.00K |
| SG&A Expenses | 1.12M | 1.26M | 1.08M | 1.23M | 1.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.49M | 2.41M | 2.29M | 2.58M | 2.50M |
| Operating Income | -1.23M | -1.53M | -1.30M | -1.37M | -1.12M |
| Income Before Tax | -1.23M | -1.14M | -1.30M | -1.32M | 5.00K |
| Income Tax Expenses | 6.00K | 6.00K | 8.00K | 5.00K | 3.00K |
| Earnings from Continuing Operations | -1.23M | -1.15M | -1.31M | -1.32M | 2.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.23M | -1.15M | -1.31M | -1.32M | 2.00K |
| EBIT | -1.23M | -1.53M | -1.30M | -1.37M | -1.12M |
| EBITDA | -1.21M | -1.52M | -1.28M | -1.35M | -1.10M |
| EPS Basic | -0.37 | -0.37 | -0.44 | -0.45 | 0.00 |
| Normalized Basic EPS | -0.23 | -0.52 | -0.27 | -0.28 | -0.26 |
| EPS Diluted | -0.37 | -0.38 | -0.44 | -0.45 | 0.00 |
| Normalized Diluted EPS | -0.23 | -0.52 | -0.27 | -0.28 | -0.26 |
| Average Basic Shares Outstanding | 3.30M | 3.10M | 3.01M | 2.91M | 2.64M |
| Average Diluted Shares Outstanding | 3.30M | 3.10M | 3.01M | 2.91M | 2.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |